Welcome to our innovation journey

About us

We are a dynamic, early-stage biotech on a mission to end organ failure, starting with the kidney. Our research into what causes organ dysfunction is uncovering new biological targets in how cells become programmed to die and our novel approach to drug development, assisted by emerging machine-learning techniques, is enabling us to engineer a number of drugs that specifically target kidney cells and prevent them from dying.

Pre-clinical data for our most advanced programs suggest this approach could deliver safe and effective drugs for a number of kidney disease including Acute Kidney Injury (AKI). This devastating condition affects 1 in 4 hospitalized patients, manifesting itself in millions of people who develop sepsis, experience trauma, are treated with certain medications or who undergoing surgery, including transplant. It is also on the rise in the community. It can have life threatening consequences, currently can’t be prevented and there is no treatment available.

Our research into functional proteomics is also revealing novel protein biomarkers that could change how patients are diagnosed, and allow detection of early stage kidney failure before traditional, surrogate endpoints are currently able to.

In short, we are only just beginning!

Our People

Like our approach to drug development, the Atorvia team is well differentiated: in addition to world class scientists with backgrounds in industry and academia, the team is strong in discovery, translation, clinical development and commercialization - including market access and reimbursement. We ensure our cutting-edge science programs incorporate commercial strategies from the onset and start with the end in mind: a focus on the patient, the physician, and the payer.

We believe that being unique is powerful, and this applies as much to our people as it does to our strategy, so we are building a company that celebrates diversity and a culture where difference is valued.  Although we are small, we are mighty, and we approach our work fearlessly. A women- and BIPOC- founded and led company, we have an inclusive workplace with a global mindset and welcome brilliant people to join us on our journey who will be themselves.

If you’re driven to perform, you’ll fit right in. We are nimble, learn quickly, improve constantly, and celebrate our wins at every turn.

Put simply, we hire the best, then let you shine.

If you are interested in Atorvia’s journey and believe you could complement the team, help accelerate and advance our work and make a difference to patients with organ failure, please contact us here.

Supported by…..

Blue Ticket Sponsors

Proudly Canadian, Atorvia is headquartered in Ottawa with state-of-the-art wet lab space in Toronto at SpinUp at UTM.